Free Trial

ACM Research (ACMR) Financials

ACM Research logo
$59.85 +0.65 (+1.10%)
Closing price 05/8/2026 04:00 PM Eastern
Extended Trading
$59.78 -0.07 (-0.11%)
As of 05/8/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for ACM Research

Annual Income Statements for ACM Research

This table shows ACM Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1.03 -0.32 6.57 19 19 38 39 77 104 94
Consolidated Net Income / (Loss)
2.39 -0.87 6.57 19 22 43 51 97 131 122
Net Income / (Loss) Continuing Operations
2.39 -0.87 6.57 19 22 43 51 97 131 122
Total Pre-Tax Income
2.98 -0.33 7.38 19 19 43 67 116 166 135
Total Operating Income
3.49 0.70 6.47 18 21 39 59 96 151 109
Total Gross Profit
13 17 34 51 70 115 184 276 392 400
Total Revenue
27 37 75 108 157 260 389 558 782 901
Operating Revenue
27 37 75 108 157 260 389 558 782 901
Total Cost of Revenue
14 19 40 57 87 145 205 282 391 501
Operating Cost of Revenue
14 19 40 57 87 145 205 282 391 501
Total Operating Expenses
9.84 17 28 33 48 76 125 180 241 291
Selling, General & Admin Expense
2.67 5.89 7.99 8.06 12 15 22 41 70 69
Marketing Expense
3.91 5.50 9.61 12 17 27 40 47 65 77
Research & Development Expense
3.26 5.14 10 13 19 34 62 93 105 145
Total Other Income / (Expense), net
-0.51 -1.03 0.91 1.15 -2.20 4.35 8.33 20 15 26
Interest Expense
0.52 1.07 0.50 0.75 0.98 0.77 1.66 2.68 4.15 6.96
Interest & Investment Income
0.02 0.05 0.15 0.50 1.55 5.14 13 18 10 25
Other Income / (Expense), net
- - 1.26 1.39 -2.77 -0.02 -3.42 4.75 9.10 7.79
Income Tax Expense
0.60 0.55 0.81 -0.52 -2.38 0.13 17 19 35 13
Net Income / (Loss) Attributable to Noncontrolling Interest
1.36 -0.55 0.00 0.56 2.90 5.16 11 20 28 28
Basic Earnings per Share
$0.30 ($0.05) $0.42 $1.12 $0.34 $0.65 $0.66 $1.29 $1.67 $1.47
Weighted Average Basic Shares Outstanding
2.18M 6.87M 15.79M 16.80M 54.70M 57.65M 59.24M 60.16M 62.21M 64.18M
Diluted Earnings per Share
$0.18 ($0.05) $0.37 $0.99 $0.30 $0.58 $0.59 $1.16 $1.53 $1.37
Weighted Average Diluted Shares Outstanding
3.79M 6.87M 17.91M 19.14M 63.55M 65.36M 65.34M 64.87M 66.24M 67.31M
Weighted Average Basic & Diluted Shares Outstanding
- 12.99M 15.70M 18.14M 18.74M 19.58M 59.70M 61.10M 63.13M 65.73M

Quarterly Income Statements for ACM Research

This table shows ACM Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
27 26 18 17 24 31 31 20 30 36 8.05
Consolidated Net Income / (Loss)
34 31 23 22 31 39 39 25 36 46 14
Net Income / (Loss) Continuing Operations
34 31 23 22 31 39 39 25 36 46 14
Total Pre-Tax Income
41 32 31 26 41 43 56 27 38 49 21
Total Operating Income
30 33 23 25 38 44 44 26 32 29 23
Total Gross Profit
69 89 79 79 97 105 111 83 104 113 100
Total Revenue
145 169 170 152 202 204 223 172 215 269 244
Operating Revenue
145 169 170 152 202 204 223 172 215 269 244
Total Cost of Revenue
76 80 91 73 106 99 113 90 111 156 145
Operating Cost of Revenue
76 80 91 73 106 99 113 90 111 156 145
Total Operating Expenses
38 55 56 54 59 61 67 57 73 84 77
Selling, General & Admin Expense
6.71 12 14 16 16 17 21 13 17 22 17
Marketing Expense
11 17 9.44 14 17 16 18 16 22 22 16
Research & Development Expense
20 26 32 24 26 28 28 28 34 40 44
Total Other Income / (Expense), net
11 -1.46 8.05 1.23 3.14 -1.51 12 1.39 6.47 20 -2.26
Interest Expense
0.65 0.64 0.70 0.78 0.93 1.21 1.23 1.56 1.76 1.85 1.79
Interest & Investment Income
6.27 1.99 8.30 1.25 1.69 4.28 3.14 4.29 5.79 6.77 8.08
Other Income / (Expense), net
5.19 -2.81 0.46 0.76 2.39 -4.58 11 -1.34 2.44 15 -8.55
Income Tax Expense
7.64 0.72 8.13 4.37 9.34 4.01 17 2.15 1.89 2.69 6.57
Net Income / (Loss) Attributable to Noncontrolling Interest
6.77 5.32 5.60 4.66 7.19 7.77 8.03 4.63 6.51 11 6.16
Basic Earnings per Share
$0.45 $0.43 $0.29 $0.28 $0.39 $0.49 $0.51 $0.32 $0.47 $0.56 $0.12
Weighted Average Basic Shares Outstanding
59.90M 60.22M 60.16M 61.37M 62.18M 62.50M 62.21M 63.27M 63.97M 64.38M 64.18M
Diluted Earnings per Share
$0.41 $0.39 $0.29 $0.26 $0.35 $0.45 $0.47 $0.30 $0.44 $0.52 $0.11
Weighted Average Diluted Shares Outstanding
64.93M 65.45M 64.87M 66.24M 67.06M 66.67M 66.24M 66.95M 67.46M 68.41M 67.31M
Weighted Average Basic & Diluted Shares Outstanding
60.02M 60.61M 61.10M 62.01M 62.47M 62.63M 63.13M 63.86M 64.18M 64.88M 65.73M

Annual Cash Flow Statements for ACM Research

This table details how cash moves in and out of ACM Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
5.72 7.56 9.96 91 -46 491 -315 -65 228 355
Net Cash From Operating Activities
-7.35 -8.10 6.91 9.40 -14 -40 -62 -75 152 -10
Net Cash From Continuing Operating Activities
-3.70 -8.10 6.91 9.40 -14 -40 -62 -75 152 -10
Net Income / (Loss) Continuing Operations
2.39 -0.87 6.57 19 22 43 51 97 131 122
Consolidated Net Income / (Loss)
-2.39 -0.87 6.57 19 22 43 51 97 131 122
Depreciation Expense
0.19 0.27 0.42 0.79 1.06 2.35 5.37 8.09 9.97 16
Non-Cash Adjustments To Reconcile Net Income
-1.99 1.59 3.24 4.40 -0.26 37 118 49 137 -19
Changes in Operating Assets and Liabilities, net
0.49 -9.09 -3.32 -15 -36 -123 -236 -229 -126 -130
Net Cash From Investing Activities
-0.81 -24 -2.07 -5.53 -70 -11 -266 -6.75 -12 -390
Net Cash From Continuing Investing Activities
-0.81 -24 -2.07 -5.53 -70 -11 -266 -6.75 -12 -390
Purchase of Property, Plant & Equipment
-0.80 -0.65 -1.83 -0.97 -5.21 -9.15 -91 -62 -82 -56
Acquisitions
-0.02 -1.32 -0.24 -0.15 -0.32 -0.56 -1.43 -2.46 -3.49 -1.37
Purchase of Investments
0.00 -0.95 0.00 -4.41 -15 -1.57 -5.28 -26 -26 -0.48
Sale and/or Maturity of Investments
- - 0.00 0.00 0.56 0.00 4.58 110 175 56
Other Investing Activities, net
0.00 -21 0.00 0.00 -50 0.00 -172 -26 -75 -389
Net Cash From Financing Activities
11 39 5.12 87 33 539 46 19 92 742
Net Cash From Continuing Financing Activities
11 39 5.12 87 33 539 46 19 92 742
Repayment of Debt
-7.72 -11 -13 -14 -22 -42 -11 -57 -42 -108
Repurchase of Common Equity
- - 0.00 -2.83 - - - 0.00 0.00 -6.99
Payment of Dividends
- - - - - - 0.00 -3.95 -6.90 -7.58
Issuance of Debt
5.92 11 18 18 52 30 56 74 130 207
Issuance of Common Equity
0.00 33 0.00 86 0.00 546 - 0.00 0.00 623
Other Financing Activities, net
3.31 -0.14 0.53 -0.26 2.75 5.25 1.31 6.14 11 35
Effect of Exchange Rate Changes
-0.32 0.66 - -0.58 4.57 3.91 -33 -1.74 -4.84 13
Cash Interest Paid
0.18 0.28 0.50 0.75 0.98 0.77 1.66 2.68 4.15 6.96
Cash Income Taxes Paid
- - 0.00 1.16 4.97 1.13 3.59 26 11 32

Quarterly Cash Flow Statements for ACM Research

This table details how cash moves in and out of ACM Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
Net Change in Cash & Equivalents
-2.85 -50 -24 29 113 10 76 57 -15 614 -301
Net Cash From Operating Activities
11 -18 -38 -9.65 62 12 89 5.28 -45 -4.63 34
Net Cash From Continuing Operating Activities
11 -18 -38 -9.65 62 12 89 5.28 -45 -4.63 34
Net Income / (Loss) Continuing Operations
34 31 23 22 31 39 39 25 36 46 14
Consolidated Net Income / (Loss)
34 31 23 22 31 39 39 25 36 46 14
Depreciation Expense
2.24 2.07 2.07 2.52 2.17 2.39 2.89 3.02 3.34 4.10 5.87
Non-Cash Adjustments To Reconcile Net Income
29 11 -17 24 42 24 48 13 -12 -20 0.22
Changes in Operating Assets and Liabilities, net
-54 -62 -47 -58 -14 -54 -1.41 -36 -73 -35 14
Net Cash From Investing Activities
-7.58 -49 0.54 12 20 -23 -21 -17 -14 -11 -348
Net Cash From Continuing Investing Activities
-7.58 -49 0.54 12 20 -23 -21 -17 -14 -11 -348
Purchase of Property, Plant & Equipment
-6.74 -28 -12 -25 -13 -33 -11 -17 -15 -11 -14
Acquisitions
-1.13 -0.33 -0.85 -0.67 -0.48 -0.83 -1.50 -0.38 -0.41 0.00 -0.59
Purchase of Investments
-0.73 -23 -1.27 -7.40 -1.37 - -17 0.00 - -0.48 -0.01
Sale and/or Maturity of Investments
0.73 12 18 91 47 21 16 10 17 10 19
Other Investing Activities, net
0.28 -9.09 -3.19 -45 -13 -11 -5.92 -10 -16 -10 -352
Net Cash From Financing Activities
4.87 3.60 12 27 31 19 15 67 44 627 4.37
Net Cash From Continuing Financing Activities
4.87 3.60 12 27 31 19 15 67 44 627 4.37
Repayment of Debt
0.59 -50 -5.85 -1.48 -2.92 -33 -4.84 -25 -15 -37 -30
Issuance of Debt
- 57 17 24 33 58 16 70 65 45 28
Other Financing Activities, net
4.28 0.77 0.85 4.80 1.64 0.05 4.61 23 0.85 4.31 6.87
Effect of Exchange Rate Changes
-11 13 1.81 -0.55 0.21 2.97 -7.46 0.87 0.65 3.43 7.88
Cash Interest Paid
0.65 0.64 0.70 0.78 0.93 1.21 1.23 1.56 1.76 1.85 1.79
Cash Income Taxes Paid
4.37 9.23 9.63 0.00 9.11 0.69 1.42 11 13 6.55 2.42

Annual Balance Sheets for ACM Research

This table presents ACM Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
44 68 103 218 341 1,052 1,236 1,491 1,856 2,872
Total Current Assets
40 63 96 198 261 953 964 1,176 1,483 2,437
Cash & Equivalents
10 18 27 58 72 563 248 182 407 757
Restricted Cash
- - 0.00 60 - 0.52 0.50 1.08 3.87 8.59
Short-Term Investments
- - - 0.00 28 29 20 21 19 36
Accounts Receivable
18 29 28 34 66 125 216 326 430 555
Inventories, net
12 15 39 45 89 218 393 545 598 703
Prepaid Expenses
0.72 0.55 1.99 2.05 5.89 14 16 20 7.51 11
Other Current Assets
0.05 0.05 - - - 2.38 70 81 17 367
Plant, Property, & Equipment, net
2.26 2.34 3.71 3.62 8.19 14 83 202 269 315
Total Noncurrent Assets
1.86 2.64 3.31 16 72 85 189 113 103 121
Long-Term Investments
0.00 1.24 1.36 5.93 6.34 13 17 28 37 66
Intangible Assets
0.02 0.11 0.27 0.34 0.55 0.48 1.26 2.54 3.46 2.85
Noncurrent Deferred & Refundable Income Taxes
1.84 1.29 1.64 5.33 11 13 6.70 20 15 29
Other Noncurrent Operating Assets
- 0.00 0.04 4.08 54 59 163 62 48 22
Total Liabilities & Shareholders' Equity
44 68 103 218 341 1,052 1,236 1,491 1,856 2,872
Total Liabilities
24 28 51 60 133 241 423 565 760 942
Total Current Liabilities
17 22 46 54 103 206 396 501 641 746
Short-Term Debt
4.77 5.10 9.45 14 28 12 58 38 77 109
Accounts Payable
9.14 13 27 26 54 133 168 256 277 398
Current Deferred Revenue
0.22 0.14 - 9.13 1.34 56 158 185 252 205
Current Deferred & Payable Income Tax Liabilities
0.04 0.04 1.19 3.13 0.03 0.25 3.47 6.40 13 0.99
Other Current Liabilities
0.00 3.08 8.42 1.36 19 4.60 8.07 15 22 33
Total Noncurrent Liabilities
6.88 6.22 4.58 6.72 30 35 27 64 119 196
Long-Term Debt
- - - 0.00 18 23 19 54 106 179
Other Noncurrent Operating Liabilities
6.88 6.22 4.58 6.72 11 10 8.43 10 13 17
Commitments & Contingencies
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2.49 40 52 97 208 812 812 926 1,096 1,931
Total Preferred & Common Equity
-2.43 40 52 97 141 676 675 767 905 1,464
Total Common Equity
-2.44 40 52 97 141 676 675 767 905 1,464
Common Stock
7.62 50 57 83 102 595 604 630 677 1,116
Retained Earnings
-9.64 -9.96 -3.39 16 34 64 94 157 260 350
Accumulated Other Comprehensive Income / (Loss)
-0.41 0.12 -0.86 -1.68 4.86 9.11 -41 -49 -63 -36
Other Equity Adjustments
- - - - - 8.31 17 30 31 34
Noncontrolling Interest
4.92 - - 0.00 67 135 137 159 191 466

Quarterly Balance Sheets for ACM Research

This table presents ACM Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets
1,072 1,148 1,313 1,317 1,410 1,557 1,668 1,794 1,934 2,040 2,771
Total Current Assets
901 971 994 997 1,116 1,229 1,343 1,445 1,548 1,646 2,358
Cash & Equivalents
324 336 260 257 207 211 324 333 457 442 1,059
Restricted Cash
0.63 0.37 0.46 0.58 0.56 0.81 0.88 1.78 11 11 8.43
Short-Term Investments
24 14 13 6.38 22 19 20 20 18 21 40
Accounts Receivable
171 203 222 236 286 349 350 430 424 478 528
Inventories, net
288 328 473 471 507 581 603 629 610 648 676
Prepaid Expenses
19 18 19 19 18 20 19 11 11 14 15
Other Current Assets
73 71 5.31 6.00 76 48 27 20 17 31 31
Plant, Property, & Equipment, net
57 66 150 159 191 219 229 250 277 291 297
Total Noncurrent Assets
114 110 169 161 103 109 96 99 109 103 116
Long-Term Investments
13 19 17 16 22 31 32 34 55 57 64
Intangible Assets
0.66 0.87 1.23 2.11 2.16 2.80 2.84 2.84 3.00 2.85 2.71
Noncurrent Deferred & Refundable Income Taxes
11 6.58 13 11 16 21 21 13 16 22 27
Other Noncurrent Operating Assets
90 84 138 132 63 53 40 49 35 21 23
Total Liabilities & Shareholders' Equity
1,072 1,148 1,313 1,317 1,410 1,557 1,668 1,794 1,934 2,040 2,771
Total Liabilities
284 374 480 484 532 596 666 725 778 848 885
Total Current Liabilities
253 346 450 456 482 533 586 610 629 671 678
Short-Term Debt
7.23 53 59 57 41 61 74 64 93 115 94
Accounts Payable
142 139 188 179 225 259 275 302 255 295 339
Current Deferred Revenue
97 142 185 201 196 187 211 226 252 235 219
Current Deferred & Payable Income Tax Liabilities
2.03 8.56 8.58 10 11 11 11 6.80 6.17 0.25 0.00
Other Current Liabilities
3.95 3.37 9.79 9.49 9.36 15 15 11 23 25 26
Total Noncurrent Liabilities
32 28 30 27 50 63 80 115 150 177 208
Long-Term Debt
21 19 18 16 40 53 71 106 135 163 193
Other Noncurrent Operating Liabilities
9.77 7.99 12 11 10 9.30 9.18 8.99 15 14 14
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
787 774 833 833 878 961 1,001 1,069 1,155 1,192 1,885
Total Preferred & Common Equity
655 643 692 692 729 796 833 888 949 986 1,433
Total Common Equity
655 643 692 692 729 796 833 888 949 986 1,433
Common Stock
599 601 606 613 620 647 659 670 700 705 1,105
Retained Earnings
70 91 101 124 152 174 198 229 280 310 346
Accumulated Other Comprehensive Income / (Loss)
-23 -58 -33 -62 -60 -55 -55 -41 -62 -59 -49
Other Equity Adjustments
8.31 8.31 17 17 17 30 30 30 31 31 31
Noncontrolling Interest
132 131 141 141 149 165 168 181 206 205 453

Annual Metrics And Ratios for ACM Research

This table displays calculated financial ratios and metrics derived from ACM Research's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - 64,876,451.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 64,876,451.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 1.45
Growth Metrics
- - - - - - - - - -
Profitability Metrics
- - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
2.79 0.49 5.76 18 24 39 44 80 119 99
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - 4.98% 7.84% 9.32% 4.45%
Earnings before Interest and Taxes (EBIT)
3.49 0.70 7.73 19 19 39 56 101 160 117
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3.68 0.97 8.14 20 20 41 61 109 170 134
Valuation Ratios
- - - - - - - - - -
Leverage & Solvency
- - - - - - - - - -
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -10 -1.49 4.12 -76 -55 -317 -103 94 -441
Efficiency Ratios
- - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
15 26 33 47 148 241 603 786 811 1,351
Increase / (Decrease) in Invested Capital
0.00 11 7.25 14 100 94 362 183 25 540
Book Value per Share
($1.12) $2.60 $3.27 $5.35 $7.64 $34.66 $11.35 $12.66 $14.44 $22.57
Tangible Book Value per Share
($1.13) $2.59 $3.25 $5.33 $7.61 $34.64 $11.33 $12.62 $14.39 $22.53
Total Capital
25 45 62 171 254 847 889 1,018 1,279 2,219
Total Debt
4.77 5.10 9.45 14 46 35 77 92 183 288
Total Long-Term Debt
0.00 0.00 0.00 0.00 18 23 19 54 106 179
Net Debt
-5.35 -14 -19 -110 -61 -570 -209 -140 -285 -579
Capital Expenditures (CapEx)
0.79 0.65 1.83 0.97 5.21 9.15 91 62 82 56
Debt-free, Cash-free Net Working Capital (DFCFNWC)
18 29 32 41 85 166 357 509 489 999
Debt-free Net Working Capital (DFNWC)
28 46 59 159 185 759 626 714 919 1,800
Net Working Capital (NWC)
23 41 50 145 158 747 568 675 842 1,691
Net Nonoperating Expense (NNE)
0.41 1.36 -0.81 -1.18 2.47 -4.34 -6.25 -17 -12 -23
Net Nonoperating Obligations (NNO)
-5.35 -14 -19 -110 -61 -570 -209 -140 -285 -579
Total Depreciation and Amortization (D&A)
0.19 0.27 0.42 0.79 1.06 2.35 5.37 8.09 9.97 16
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.10 ($0.02) $0.14 $0.37 $0.34 $0.65 $0.66 $1.29 $1.67 $1.47
Adjusted Weighted Average Basic Shares Outstanding
6.53M 20.60M 47.37M 50.40M 54.70M 57.65M 59.24M 60.16M 62.21M 64.18M
Adjusted Diluted Earnings per Share
$0.06 ($0.02) $0.12 $0.33 $0.30 $0.58 $0.59 $1.16 $1.53 $1.37
Adjusted Weighted Average Diluted Shares Outstanding
11.38M 20.60M 53.74M 57.41M 63.55M 65.36M 65.34M 64.87M 66.24M 67.31M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.37 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 38.98M 42.53M 54.41M 56.23M 58.74M 59.70M 61.10M 63.13M 65.73M
Normalized Net Operating Profit after Tax (NOPAT)
2.79 0.49 5.76 12 15 39 44 80 119 99
Debt Service Ratios
- - - - - - - - - -
Payout Ratios
- - - - - - - - - -

Quarterly Metrics And Ratios for ACM Research

This table displays calculated financial ratios and metrics derived from ACM Research's official financial filings.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025
DEI Shares Outstanding
- - - - - - - - - - 64,876,451.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 64,876,451.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.12
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
25 32 17 21 29 40 30 24 30 27 16
Return On Investment Capital (ROIC_SIMPLE)
- - 1.70% 1.96% - - 2.38% 1.72% 2.05% 1.26% 0.71%
Earnings before Interest and Taxes (EBIT)
36 30 24 26 40 40 55 24 34 44 14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
38 32 26 29 42 42 57 27 37 48 20
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-147 -198 -165 -173 -115 -104 5.38 -4.68 -139 -124 -524
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
626 707 786 813 770 850 811 842 939 1,001 1,351
Increase / (Decrease) in Invested Capital
172 230 183 194 144 144 25 28 169 151 540
Book Value per Share
$11.56 $12.15 $12.66 $12.97 $13.44 $14.22 $14.44 $15.03 $15.45 $22.32 $22.57
Tangible Book Value per Share
$11.52 $12.11 $12.62 $12.93 $13.39 $14.17 $14.39 $14.99 $15.40 $22.28 $22.53
Total Capital
906 959 1,018 1,075 1,146 1,240 1,279 1,383 1,470 2,172 2,219
Total Debt
73 80 92 115 145 171 183 227 278 287 288
Total Long-Term Debt
16 40 54 53 71 106 106 135 163 193 179
Net Debt
-207 -171 -140 -147 -231 -219 -285 -314 -253 -884 -579
Capital Expenditures (CapEx)
6.74 28 12 25 13 33 11 17 15 11 14
Debt-free, Cash-free Net Working Capital (DFCFNWC)
333 445 509 527 487 544 489 526 616 667 999
Debt-free Net Working Capital (DFNWC)
598 675 714 757 831 900 919 1,012 1,090 1,774 1,800
Net Working Capital (NWC)
541 634 675 696 757 835 842 919 975 1,680 1,691
Net Nonoperating Expense (NNE)
-8.80 1.43 -5.97 -1.03 -2.42 1.36 -8.62 -1.28 -6.15 -19 1.54
Net Nonoperating Obligations (NNO)
-207 -171 -140 -147 -231 -219 -285 -314 -253 -884 -579
Total Depreciation and Amortization (D&A)
2.24 2.07 2.07 2.52 2.17 2.39 2.89 3.02 3.34 4.10 5.87
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.45 $0.43 $0.29 $0.28 $0.39 $0.49 $0.51 $0.32 $0.47 $0.56 $0.12
Adjusted Weighted Average Basic Shares Outstanding
59.90M 60.22M 60.16M 61.37M 62.18M 62.50M 62.21M 63.27M 63.97M 64.38M 64.18M
Adjusted Diluted Earnings per Share
$0.41 $0.39 $0.29 $0.26 $0.35 $0.45 $0.47 $0.30 $0.44 $0.52 $0.11
Adjusted Weighted Average Diluted Shares Outstanding
64.93M 65.45M 64.87M 66.24M 67.06M 66.67M 66.24M 66.95M 67.46M 68.41M 67.31M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.29 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
60.02M 60.61M 61.10M 62.01M 62.47M 62.63M 63.13M 63.86M 64.18M 64.88M 65.73M
Normalized Net Operating Profit after Tax (NOPAT)
25 32 17 21 29 40 30 24 30 27 16
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

Here are the key trends from ACM Research (ACMR) across the last four years of quarterly statements. Bullets are ordered to emphasize potential positives first, then neutrals, then negatives.

  • Strong liquidity in recent quarters: Cash and cash equivalents were around $1.06 billion as of Q3 2025, with about $8.4 million in restricted cash, providing substantial liquidity headroom.
  • Revenue continued to scale in 2025: Q4 2025 revenue reached $244.43 million, up from $223.47 million in Q4 2024, indicating year-over-year top-line growth.
  • Positive operating cash flow in the latest quarter: Net cash from continuing operating activities was $33.9 million in Q4 2025, showing ongoing cash generation from core operations.
  • Gross margins remained solid in 2025: 2025 quarters typically posted gross margins in the low- to mid-40% range (example: Q4 2025 gross margin about 40.9%), signaling decent profitability on revenue.
  • Asset growth and liquidity cushion: Total assets rose to about $2.77 billion by Q3 2025, with current assets around $2.36 billion and current liabilities near $678 million, suggesting strong liquidity coverage.
  • Profitability oscillates quarter to quarter: Net income and earnings per share have fluctuated across quarters (e.g., Q4 2025 net income continuing roughly $14.2 million vs higher quarters earlier in 2025), implying variability in quarterly profitability.
  • Cash flow from investing is consistently negative in some periods: Several quarters show sizable investing outflows (PPE purchases, acquisitions, etc.), contributing to negative free cash flow in those periods.
  • Q4 2025 net income and EPS weakened vs prior year: Net income per share declined in Q4 2025 (basic EPS about $0.12; diluted EPS about $0.11) compared with Q4 2024, signaling margin deterioration.
  • Q4 2025 cash burn despite operating gains: Net change in cash and equivalents for Q4 2025 was negative by about $301.4 million, driven by investing outflows, despite positive operating cash flow in that quarter.
  • Quarterly profitability and dilution considerations remain mixed: While several quarters show positive net income and EPS, the mix across 2025 includes softer late-quarter results and substantial financing activity in some periods, which can introduce volatility for shareholders.
05/09/26 09:05 AM ETAI Generated. May Contain Errors.

ACM Research Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ACM Research's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

ACM Research's net income appears to be on an upward trend, with a most recent value of $121.89 million in 2025, rising from $2.39 million in 2016. The previous period was $131.27 million in 2024. See ACM Research's forecast for analyst expectations on what's next for the company.

ACM Research's total operating income in 2025 was $109.43 million, based on the following breakdown:
  • Total Gross Profit: $400.07 million
  • Total Operating Expenses: $290.64 million

Over the last 9 years, ACM Research's total revenue changed from $27.37 million in 2016 to $901.31 million in 2025, a change of 3,192.9%.

ACM Research's total liabilities were at $941.68 million at the end of 2025, a 23.9% increase from 2024, and a 3,832.2% increase since 2016.

In the past 9 years, ACM Research's cash and equivalents has ranged from $10.12 million in 2016 to $757.37 million in 2025, and is currently $757.37 million as of their latest financial filing in 2025.

Over the last 9 years, ACM Research's book value per share changed from -1.12 in 2016 to 22.57 in 2025, a change of -2,116.6%.



Financial statements for NASDAQ:ACMR last updated on 3/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners